HOME >> BIOLOGY >> NEWS
Markers of gene, protein, or micro-RNA activity predict outcome in prostate and colorectal cancers

WASHINGTON, D.C. - Cancer researchers are working toward a future in which each patient's tumor will act like a crystal ball, revealing how oncologists should treat the cancer to obtain the best outcome. Currently, physicians cannot predict which patients with prostate cancer should receive extra therapy after surgery - or whether some of these patients have an indolent disease that does not even require surgery. Most patients with colorectal cancer have surgery, but some, even at the earliest stages, could benefit from additional treatment - if physicians only knew who. Some of the genes and proteins specific to cancer cells can be used for prognostic purposes, as can the newest type of biomarker, mcro-RNAs, according to studies presented today at the 97th Annual Meeting of the American Association for Cancer Research.

The Serological Markers TIMP-1, PAI-1, MASP-2 and CRP are Independent Predictors of Colorectal Cancer-Specific Death: Abstract No. 5723

Oncologists say it is very difficult to predict which patients with colorectal cancer will be cured by surgery alone - the single treatment most patients receive - and who might benefit from the addition of chemotherapy. Now, however, a Danish research team has found that just four protein biomarkers can predict death from colorectal cancer, independent of the stage or location of the cancer, or the age or gender of the patient.

In this study, blood taken from 654 colorectal cancer patients just before they had surgery was retrospectively analyzed for expression of the proteins. The test was not perfect, but it significantly identified the 308 patients who later died of the disease, some up to nine years later.

"The results show that the outcome of a significant number of patients was correctly identified, independent of stage and location," said the lead author, Hans J. Nielsen, M.D, DMSc., Professor of Surgical Oncology, at Hvidovre University Hospital.

When tumor
'"/>

Contact: Warren R. Froelich
froelich@aacr.org
215-440-9300
American Association for Cancer Research
5-Apr-2006


Page: 1 2 3 4 5 6 7

Related biology news :

1. Markers found for bacterial vaginosis
2. Markers of brain cell development may help success of stem cell transplants
3. Molecule blocks gene, sheds light on liver cancer
4. Biologist to receive $500,000 MacArthur grant for genius in innovative gene, molecule studies
5. Silence the gene, save the cell: RNA interference as promising therapy for ALS
6. One protein, two channels: Scientists explain mechanism in aquaporins
7. HIV infection requires B cells with special protein, University of Pittsburgh researchers report
8. UC Davis researchers discover new link between C-reactive protein, and heart disease and stroke
9. Prenatal alcohol exposure alters brain activity in the frontal-striatal areas
10. Genes activity points to more lethal subtype of AML
11. Weizmann Institute scientists develop a general control switch for protein activity

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/5/2019)... ... March 05, 2019 , ... Join this live ... metadata-driven approach will help data analysts and bioinformaticians focus on data analysis without worrying ... that can come from different source systems. Some sources of data include:, ...
(Date:2/27/2019)... ... February 27, 2019 , ... Fluxion Biosciences, a leading developer of precision solutions ... Cancer Institute grant for further development of its ERASE-Seq liquid biopsy technology. The Phase ... lab of Dr. Omar Mian at the Cleveland Clinic. , Liquid biopsies offer the ...
(Date:2/22/2019)... ... February 20, 2019 , ... ... plans today to expand the company’s footprint in Frederick, MD after a year ... used RoosterBio’s adult human mesenchymal stem/stromal cell (hMSCs) products to streamline their product ...
Breaking Biology News(10 mins):
(Date:3/9/2019)... DIEGO (PRWEB) , ... March 07, 2019 , ... ... Technologies, is a pioneer in the development and commercialization of high performance, cutting-edge ... PhysioStim, a leading European CRO with GLP-certified expertise in cardiovascular pharmacology and electrophysiology, ...
(Date:3/5/2019)... Texas (PRWEB) , ... March 05, 2019 , ... ... a biopharmaceutical cold chain engineering firm with regulatory filing authorities, logistics network experts, ... corporate information to initiate its participation in the Inc. Verified Profile program, Inc. ...
(Date:2/27/2019)... ... February 26, 2019 , ... Superior Controls, Inc., a leading ... 140 employees on both the east and west coasts, today announced that employee ... New Hampshire. Sandmaier, a senior project engineer, joins Taggart McCormick, P.E., Anthony Whitesell, ...
(Date:2/22/2019)... ... February 20, 2019 , ... Superior Controls, Inc. ... solutions with 140 employees on both the east and west coasts, today announced the ... working out of the company’s Seabrook, New Hampshire office. In his new role, ...
Breaking Biology Technology:
Cached News: